SEC Form 4/A · accession 0001104659-16-130130
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Alan Joslyn
Director
Period of report
Jun 24, 2016
Accepted (ET)
Jun 29, 2016 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $3.67 | Jun 24, 2016 | A | 62,500 | A | Jun 24, 2017 | Jun 24, 2026 | Common Stock | 62,500 | 259,020 | D |
Explanation of responses
- F1This form is being amended to reflect that the options vest on June 24, 2017.